LabCorp Extends Offer for Monogram; Aims to Settle with Shareholders | GenomeWeb

NEW YORK (GenomeWeb News) – Laboratory Corporation of America has extended until the end of the day on Aug. 3 its previously announced cash tender offer to acquire all of the outstanding shares of common stock of Monogram Biosciences.

LabCorp announced its intention to acquire Monogram for $107 million last month, and the tender offer was set to expire at the end of the day on July 29.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.